OTCMKTS:SZLSF StageZero Life Sciences (SZLSF) Stock Forecast, Price & News $0.03 -0.02 (-40.00%) (As of 06/7/2023 ET) Add Compare Share Share Today's Range$0.03▼$0.0450-Day Range$0.03▼$0.0852-Week Range$0.03▼$0.10Volume3,575 shsAverage Volume1,184 shsMarket Capitalization$3.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort Interest About StageZero Life Sciences (OTCMKTS:SZLSF) StockStageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall on February 20, 1997 and is headquartered in Richmond Hill, Canada.Read More Receive SZLSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address SZLSF Stock News HeadlinesJune 7, 2023 | finance.yahoo.comStageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special MeetingMay 17, 2023 | theglobeandmail.comDually-Listed Healthcare Stock Rallies On Q1 ResultsJune 8, 2023 | Behind the Markets (Ad)The 4th Military Revolution is Happening. There have been 3 military revolutions in the past 100 years. The first was when the tank was invented in 1915. The second was the nuclear bomb in 1945. The third was the "smart bomb" in 1991. Amid the turmoil, there will be many losers. Click here to see how to win instead >>>May 15, 2023 | finance.yahoo.comStageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023April 4, 2023 | msn.comStagezero Life Sciences GAAP EPS of -$0.09, revenue of $0.7MMarch 30, 2023 | finance.yahoo.comStageZero to Issue Q4 2022 Financial Results on Friday March 31March 29, 2023 | finance.yahoo.comStageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30February 15, 2023 | finance.yahoo.comResults from METRICs Study Informs Expansion of StageZero's New Care Oncology ProtocolJune 8, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Software" to Revolutionize WarfareThis breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>January 12, 2023 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023January 12, 2023 | finance.yahoo.comStageZero Life Sciences Announces Extension of Warrants Expiring in January 2023November 15, 2022 | seekingalpha.comStageZero Life Sciences Ltd. (SZLSF) Q3 2022 Earnings Call TranscriptNovember 12, 2022 | finance.yahoo.comStageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022August 19, 2022 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Announces Solutions for Employers to Help Improve Cancer OutcomesAugust 12, 2022 | finance.yahoo.comStageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022May 26, 2022 | seekingalpha.comStageZero Life Sciences CFO resignsMay 25, 2022 | finance.yahoo.comStageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USAMay 17, 2022 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational UpdateMay 17, 2022 | finance.yahoo.comStageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational UpdateApril 6, 2022 | finance.yahoo.comStageZero Life Sciences, Ltd Announces Corporate UpdateApril 1, 2022 | finance.yahoo.comStageZero Life Sciences, Ltd Announces Q4 2021 and Year End Financial Results and Operational UpdateMarch 31, 2022 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences Launches AVRT in the UKMarch 31, 2022 | finance.yahoo.comStageZero Life Sciences Launches AVRT(TM) in the UKMarch 14, 2022 | finanznachrichten.deStageZero Life Sciences Ltd: CORRECTING AND REPLACING: StageZero Life Sciences Announces Availability of COC Protocol in EuropeMarch 14, 2022 | lse.co.ukCQN:StageZero Announces COC Protocol in EuropeMarch 14, 2022 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences Announces Availability of COC Protocol in EuropeMarch 14, 2022 | finance.yahoo.comStageZero Life Sciences Announces Availability of COC Protocol in EuropeSee More Headlines SZLSF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SZLSF Company Calendar Last Earnings3/31/2023Today6/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:SZLSF CUSIPN/A CIK1454263 Webwww.stagezerolifesciences.com Phone(855) 420-7140Fax905-209-2031Employees51Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,410,000.00 Net Margins-388.59% Pretax Margin-91.19% Return on Equity-877.87% Return on Assets-148.07% Debt Debt-to-Equity Ratio0.44 Current Ratio0.08 Quick Ratio0.04 Sales & Book Value Annual Sales$3.80 million Price / Sales0.83 Cash FlowN/A Price / Cash FlowN/A Book Value$0.03 per share Price / Book1.00Miscellaneous Outstanding Shares105,460,000Free Float102,786,000Market Cap$3.16 million OptionableNot Optionable Beta0.57 Key ExecutivesJames R. Howard-TrippExecutive Chairman & Chief Executive OfficerRebecca GrecoHead-Investor RelationsKey CompetitorsVirax Biolabs GroupNASDAQ:VRAXNavidea BiopharmaceuticalsNYSE:NAVBStageZero Life SciencesOTCMKTS:GNWSFLucira HealthNASDAQ:LHDXQLucira HealthNASDAQ:LHDXView All Competitors SZLSF Stock - Frequently Asked Questions How have SZLSF shares performed in 2023? StageZero Life Sciences' stock was trading at $0.0443 on January 1st, 2023. Since then, SZLSF shares have decreased by 32.3% and is now trading at $0.03. View the best growth stocks for 2023 here. How were StageZero Life Sciences' earnings last quarter? StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) posted its earnings results on Friday, March, 31st. The company reported ($0.09) EPS for the quarter. The business earned $0.68 million during the quarter. StageZero Life Sciences had a negative net margin of 388.59% and a negative trailing twelve-month return on equity of 877.87%. What is StageZero Life Sciences' stock symbol? StageZero Life Sciences trades on the OTCMKTS under the ticker symbol "SZLSF." How do I buy shares of StageZero Life Sciences? Shares of SZLSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is StageZero Life Sciences' stock price today? One share of SZLSF stock can currently be purchased for approximately $0.03. How much money does StageZero Life Sciences make? StageZero Life Sciences (OTCMKTS:SZLSF) has a market capitalization of $3.16 million and generates $3.80 million in revenue each year. The company earns $-11,410,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis. How can I contact StageZero Life Sciences? StageZero Life Sciences' mailing address is 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2. The official website for the company is www.stagezerolifesciences.com. The company can be reached via phone at (855) 420-7140, via email at rgreco@stagezerols.com, or via fax at 905-209-2031. This page (OTCMKTS:SZLSF) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.